SOPH CMO Philippe Menu Sells 5,000 Shares

What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares on August 12, 2026. The Form 4 reports a weighted-average sale price of $7.52, for total proceeds of approximately $37,580. This was a sale (not a purchase or grant).

Key Details

• Transaction date: 2026-08-12 (Period of Report)
• Report filed: 2026-08-14 (filed two days after the trade — generally timely for Form 4)
• Shares sold: 5,000; weighted-average price reported: $7.52; total proceeds ≈ $37,580
• Price range: shares sold in multiple trades at prices between $7.40 and $7.60 (per footnote)
• Shares owned after the transaction: not provided in the details you supplied (check the full Form 4 for post-transaction holdings)
• Footnotes: F1 — sale was made pursuant to a pre-established Rule 10b5-1 trading plan; F2 — reported price is a weighted average and a breakdown by individual trade price can be provided on request

Context
Sales executed under a 10b5-1 plan are typically pre-arranged and can be routine liquidity or diversification events; they do not necessarily signal a change in the insider’s view of the company. For investment decisions, consider overall insider trading patterns and company fundamentals rather than a single sale.